Cargando…
Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP
BACKGROUND: Human T-lymphotropic virus 1 (HTLV-1) is etiologically associated with the chronic inflammatory neurodegenerative disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) Annexin A1 (AnxA1) is an anti-inflammatory protein with proposed neuroprotective and anti-neuroinf...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908672/ https://www.ncbi.nlm.nih.gov/pubmed/33632146 http://dx.doi.org/10.1186/s12879-021-05917-y |
_version_ | 1783655768538480640 |
---|---|
author | Santana, Bárbara Brasil Queiroz, Maria Alice Freitas Cerveira, Rodrigo Arcoverde Rodrigues, Claudia Mendonça da Silva Graça Amoras, Ednelza da Costa, Carlos Araújo de Sousa, Maisa Silva Ishak, Ricardo Goulart, Luiz Ricardo Vallinoto, Antonio Carlos Rosário |
author_facet | Santana, Bárbara Brasil Queiroz, Maria Alice Freitas Cerveira, Rodrigo Arcoverde Rodrigues, Claudia Mendonça da Silva Graça Amoras, Ednelza da Costa, Carlos Araújo de Sousa, Maisa Silva Ishak, Ricardo Goulart, Luiz Ricardo Vallinoto, Antonio Carlos Rosário |
author_sort | Santana, Bárbara Brasil |
collection | PubMed |
description | BACKGROUND: Human T-lymphotropic virus 1 (HTLV-1) is etiologically associated with the chronic inflammatory neurodegenerative disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) Annexin A1 (AnxA1) is an anti-inflammatory protein with proposed neuroprotective and anti-neuroinflammatory functions. We hypothesized that ANXA1 gene expression may be dysregulated in HTLV-1-infected HAM/TSP patients. METHODS: This study involved 37 individuals infected with HTLV-1, including 21 asymptomatic (AS) carriers and 16 with HAM/TSP, and a control group of 30 individuals negative for HTLV-1 and HTLV-2. For AS HTLV-1-positive and HAM/TSP patients, ANXA1 and formyl peptide receptor (FPR1, FPR2 and FPR3) expression and HTLV-1 proviral load (PVL) in peripheral blood cells were evaluated by real-time quantitative PCR (qPCR), and plasma AnxA1 levels were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS: ANXA1 gene expression was increased in the AS group compared with the HAM/TSP and control groups, but the differences were not statistically significant. FPR1 gene expression was higher in patients with HTLV-1 than in controls (AS, p = 0.0032; HAM/TSP, p < 0.0001). Plasma AnxA1 levels were higher in the AS group than in the HAM/TSP group (p = 0.0045), and PVL was higher in patients with HAM/TSP than in AS individuals (p = 0.0162). The use of a combined ROC curve using Annexin 1 levels and proviral load significantly increased the sensitivity and specificity to predict progression to HAM/TSP (AUC = 0.851 and AUC = 0.937, respectively, to AUC = 1000). CONCLUSIONS: Our results suggest that AnxA1 may be dysregulated in HAM/TSP patients. Serological detection of AnxA1 in association with proviral load may provide a prognostic biomarker for HTLV-1-associated neurodegenerative disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-05917-y. |
format | Online Article Text |
id | pubmed-7908672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79086722021-02-26 Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP Santana, Bárbara Brasil Queiroz, Maria Alice Freitas Cerveira, Rodrigo Arcoverde Rodrigues, Claudia Mendonça da Silva Graça Amoras, Ednelza da Costa, Carlos Araújo de Sousa, Maisa Silva Ishak, Ricardo Goulart, Luiz Ricardo Vallinoto, Antonio Carlos Rosário BMC Infect Dis Research Article BACKGROUND: Human T-lymphotropic virus 1 (HTLV-1) is etiologically associated with the chronic inflammatory neurodegenerative disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) Annexin A1 (AnxA1) is an anti-inflammatory protein with proposed neuroprotective and anti-neuroinflammatory functions. We hypothesized that ANXA1 gene expression may be dysregulated in HTLV-1-infected HAM/TSP patients. METHODS: This study involved 37 individuals infected with HTLV-1, including 21 asymptomatic (AS) carriers and 16 with HAM/TSP, and a control group of 30 individuals negative for HTLV-1 and HTLV-2. For AS HTLV-1-positive and HAM/TSP patients, ANXA1 and formyl peptide receptor (FPR1, FPR2 and FPR3) expression and HTLV-1 proviral load (PVL) in peripheral blood cells were evaluated by real-time quantitative PCR (qPCR), and plasma AnxA1 levels were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS: ANXA1 gene expression was increased in the AS group compared with the HAM/TSP and control groups, but the differences were not statistically significant. FPR1 gene expression was higher in patients with HTLV-1 than in controls (AS, p = 0.0032; HAM/TSP, p < 0.0001). Plasma AnxA1 levels were higher in the AS group than in the HAM/TSP group (p = 0.0045), and PVL was higher in patients with HAM/TSP than in AS individuals (p = 0.0162). The use of a combined ROC curve using Annexin 1 levels and proviral load significantly increased the sensitivity and specificity to predict progression to HAM/TSP (AUC = 0.851 and AUC = 0.937, respectively, to AUC = 1000). CONCLUSIONS: Our results suggest that AnxA1 may be dysregulated in HAM/TSP patients. Serological detection of AnxA1 in association with proviral load may provide a prognostic biomarker for HTLV-1-associated neurodegenerative disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-05917-y. BioMed Central 2021-02-25 /pmc/articles/PMC7908672/ /pubmed/33632146 http://dx.doi.org/10.1186/s12879-021-05917-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Santana, Bárbara Brasil Queiroz, Maria Alice Freitas Cerveira, Rodrigo Arcoverde Rodrigues, Claudia Mendonça da Silva Graça Amoras, Ednelza da Costa, Carlos Araújo de Sousa, Maisa Silva Ishak, Ricardo Goulart, Luiz Ricardo Vallinoto, Antonio Carlos Rosário Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP |
title | Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP |
title_full | Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP |
title_fullStr | Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP |
title_full_unstemmed | Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP |
title_short | Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP |
title_sort | low annexin a1 level in htlv-1 infected patients is a potential biomarker for the clinical progression and diagnosis of ham/tsp |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908672/ https://www.ncbi.nlm.nih.gov/pubmed/33632146 http://dx.doi.org/10.1186/s12879-021-05917-y |
work_keys_str_mv | AT santanabarbarabrasil lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT queirozmariaalicefreitas lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT cerveirarodrigoarcoverde lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT rodriguesclaudiamendonca lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT dasilvagracaamorasednelza lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT dacostacarlosaraujo lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT desousamaisasilva lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT ishakricardo lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT goulartluizricardo lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp AT vallinotoantoniocarlosrosario lowannexina1levelinhtlv1infectedpatientsisapotentialbiomarkerfortheclinicalprogressionanddiagnosisofhamtsp |